What companies are PRME's competitors?

Prime Medicine, Inc. (PRME)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does PRME compare to its peers?

The peer comparison table on this page shows Prime Medicine, Inc. (PRME) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does PRME operate in?

Prime Medicine, Inc. (PRME) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

PRME

Prime Medicine, Inc.

NASDAQ·Biotechnology · Healthcare

$2.97$0.12−3.88%

After hours·$3.05+2.69%

Market cap$536.43M·Market closed·Jul 23 8:00 PM UTC

Frequently Asked Questions About PRME

What companies are PRME's competitors?: Prime Medicine, Inc. (PRME)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does PRME compare to its peers?: The peer comparison table on this page shows Prime Medicine, Inc. (PRME) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does PRME operate in?: Prime Medicine, Inc. (PRME) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

PRME

Prime Medicine, Inc.

NASDAQ·Biotechnology · Healthcare

$2.97$0.12−3.88%

After hours·$3.05+2.69%

Market cap$536.43M·Market closed·Jul 23 8:00 PM UTC

Peers


MRVI	Maravai LifeSciences Holdings, Inc.	$7.04	$1.9B
TYRA	Tyra Biosciences, Inc.	$30.80	$1.8B
VIR	Vir Biotechnology, Inc.	$9.34	$1.6B
BCAX	Bicara Therapeutics Inc. Common Stock	$27.73	$1.5B
SEPN	Septerna Inc	$33.47	$1.5B
EYPT	EyePoint Pharmaceuticals, Inc.	$12.47	$1.0B
KURA	Kura Oncology, Inc.	$10.45	$927.7M
REPL	Replimune Group, Inc.	$10.46	$878.1M
RZLT	Rezolute, Inc.	$5.31	$511.3M
PROK	ProKidney Corp.	$1.52	$511.1M

Frequently Asked Questions About PRME

What companies are PRME's competitors?: Prime Medicine, Inc. (PRME)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does PRME compare to its peers?: The peer comparison table on this page shows Prime Medicine, Inc. (PRME) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does PRME operate in?: Prime Medicine, Inc. (PRME) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.